Melatonin Reverses Metabolic Damage in IVF Children by Fixing Liver Enzymes

Children born through in vitro fertilization (IVF) face significantly higher risks of obesity and abnormal glucose metabolism, but new research reveals both the underlying cause and a potential solution. Scientists have discovered that IVF offspring develop excessive protein acetylation in liver cells, which impairs the function of key metabolic enzymes.

The study focused on lysine acetylation, a cellular modification that regulates enzyme activity and metabolic pathways. In IVF offspring, elevated acetylation levels disrupted normal glucose metabolism in the liver, contributing to metabolic dysfunction.

The breakthrough came when researchers tested melatonin supplementation in IVF culture medium. Melatonin significantly reduced harmful acetylation levels and restored normal liver function. Most importantly, it enhanced the activity of critical enzymes including citrate synthase and isocitrate dehydrogenase, which are essential for energy production and glucose metabolism.

These findings offer hope for preventing metabolic complications in IVF children through a simple, safe intervention. Since melatonin is already used clinically and has an excellent safety profile, this approach could be readily implemented in fertility clinics. The research provides new insight into how early embryonic environments affect lifelong health and suggests that optimizing culture conditions during IVF could prevent future disease in offspring.